Globally, infant and childhood identification is needed for health care delivery, especially in remote or resource-limited areas, as well as for supporting efforts in disaster relief, human trafficking, migration and refugee settlement.
Spencer said other technologists have unsuccessfully attempted to extrapolate adult technologies to fingerprinting children. His solution was to apply a human-centered design and develop the technology from the ground up with infants, caregivers and stakeholders in mind. “Accurate identification of a child to enable timely vaccinations can improve care, reduce disease burden and save lives,” said Spencer. This technology could be usefulness in tracking vaccinations and aid or prevent infectious disease outbreaks. A person’s identity could now be secured at birth, potentially protecting from identity fraud many years in the future. “Imagine the ability to assist refugees displaced by war or natural disasters to establish their identity so they can access needed food, aid and care. While a difficult subject, this technology may have applications to help prevent human trafficking and other causes of separation of children from their families.”
Non-contact optical scanning technology
Spencer said the technology was conceived to accommodate the size, movements and behaviors of an infant. “Not only did we take into account the child’s physiology and reflexes, but also what would be culturally acceptable in different countries. For example, in some areas, facial photography is shunned, but photography of hands is acceptable.”
The device, called ION, is a non-contact optical scanning technology that can image fingers and the palm of the hand. Prints are stored as encrypted templates that can be securely shared across platforms. The current device is rugged, portable, fits in the user’s hand and works with laptops and mobile platforms. While the technology was developed to identify infants and young children, it works with high accuracy with adults, making it the first biometric platform for all ages. Enhancements under development include the capability to also measure health biometrics and other clinical data, such as temperature, pulse, breathing and oxygen.
Institution Review Board-approved clinical trials are currently underway at UC San Diego and with collaborators in Mexico. Preliminary results show that the device delivers greater than 99 percent accuracy on re-identification after registration as early as two days after birth, with 90 percent accuracy for registration on the first day of birth.
“The next stage is to take the device into the field in Africa and South Asia and broaden the populations we evaluate,” said Spencer. “While the device is not yet commercially available, we hope to have it ready for market within 12 months. We want to continue to validate the platform, work through workflow, security and ethical issues, and, with funding, make the technology available on a staged basis to non-governmental organizations and government programs at local and national levels.”